Albert Lowe

Stock Analyst at Craig-Hallum

(2.40)
# 2,612
Out of 5,045 analysts
9
Total ratings
44.44%
Success rate
16.69%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Albert Lowe

Neurogene
Jun 17, 2025
Initiates: Buy
Price Target: $50
Current: $33.28
Upside: +50.24%
Atossa Therapeutics
Jun 5, 2025
Initiates: Buy
Price Target: $4
Current: $0.89
Upside: +349.44%
Opus Genetics
Apr 11, 2025
Initiates: Buy
Price Target: $6
Current: $1.95
Upside: +207.69%
Skye Bioscience
Mar 21, 2025
Maintains: Buy
Price Target: $18$14
Current: $1.52
Upside: +824.09%
SAB Biotherapeutics
Oct 9, 2024
Initiates: Buy
Price Target: $11
Current: $3.00
Upside: +266.67%
Cardiff Oncology
Sep 6, 2024
Initiates: Buy
Price Target: $8
Current: $2.25
Upside: +255.56%
Lineage Cell Therapeutics
Aug 20, 2024
Initiates: Buy
Price Target: $4
Current: $1.85
Upside: +116.22%
PMV Pharmaceuticals
May 13, 2024
Initiates: Buy
Price Target: $6
Current: $1.41
Upside: +327.05%